US20070251529A1 - Nasal ventilation interface and system - Google Patents

Nasal ventilation interface and system Download PDF

Info

Publication number
US20070251529A1
US20070251529A1 US11/806,773 US80677307A US2007251529A1 US 20070251529 A1 US20070251529 A1 US 20070251529A1 US 80677307 A US80677307 A US 80677307A US 2007251529 A1 US2007251529 A1 US 2007251529A1
Authority
US
United States
Prior art keywords
ventilation
cannula
nasal
exhaust port
interface
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/806,773
Inventor
Thomas Wood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US11/806,773 priority Critical patent/US20070251529A1/en
Publication of US20070251529A1 publication Critical patent/US20070251529A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/06Respiratory or anaesthetic masks
    • A61M16/0666Nasal cannulas or tubing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/08Bellows; Connecting tubes ; Water traps; Patient circuits
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/08Bellows; Connecting tubes ; Water traps; Patient circuits
    • A61M16/0816Joints or connectors
    • A61M16/0833T- or Y-type connectors, e.g. Y-piece

Definitions

  • Obstructive sleep apnea syndrome (commonly referred to as obstructive sleep apnea, sleep apnea syndrome, and/or sleep apnea) is a medical condition which includes repeated, prolonged episodes of cessation of breathing during sleep.
  • the muscles of the upper part of the throat passage of an individual keep the passage open, thereby permitting an adequate amount of oxygen to flow into the lungs.
  • the throat passage tends to narrow due to the relaxation of the muscles. In those individuals having a relatively normally sized throat passage, the narrowed throat passage remains open enough to continue to permit the adequate amount of oxygen to flow into the lungs.
  • the narrowed throat passage prohibits the adequate amount of oxygen from flowing into the lungs.
  • a nasal obstruction such as a relatively laze tongue, and/or certain shapes of the palate and/or the jaw of the individual further prohibit the adequate amount of oxygen from flowing into the lungs.
  • the individual having the above discussed conditions can stop breathing for one or more prolonged periods of time (e.g., 10 seconds or more).
  • the prolonged periods of time during which breathing is stopped, or apneas are generally followed by reflexive attempts to breathe.
  • the reflexive attempts to breathe are generally accompanied by a change from a relatively deeper stage of sleep to a relatively lighter stage of sleep.
  • the individual suffering from obstructive sleep apnea syndrome generally experiences fragmented sleep that is not restful.
  • the fragmented sleep results in one or more of excessive and/or inappropriate daytime drowsiness, headache, weight gain or loss, limited attention span, memory loss, poor judgment, personality changes, lethargy, inability to maintain concentration, and/or depression.
  • Other medical conditions can also prevent individuals, including adults and infants, from receiving the adequate amount of oxygen into the lungs. For example, an infant who is born prematurely can have lungs that are not developed to an extent necessary to receive the adequate amount of oxygen. Further, prior to, during, and/or subsequent to certain medical procedures and/or medical treatments, an individual can be unable to receive the adequate amount of oxygen.
  • a ventilation interface to apply a positive pressure to the throat of the individual, thereby permitting the adequate amount of oxygen to flow into the lungs.
  • oxygen and/or room air containing oxygen is delivered through the mouth and/or nose of the individual.
  • CPAP continuous positive airway pressure
  • BiPAP bi-level positive airway pressure
  • IPPV intermittent mechanical positive pressure ventilation
  • One conventional ventilation interface for he application of such positive pressures includes a face mask that covers the nose and/or mouth, as well as a pair of nasal pillows that are inserted into corresponding nares of the naris.
  • the harness is generally uncomfortable to wear, particularly when sleeping.
  • the applied pressure often results in undesirable irritation and sores caused by movement of the mask and harness during periods of both wakefulness and sleep.
  • the required seal is generally difficult to maintain when the mask and harness is moved.
  • the mask also generally applies an undesirable pressure to the sinus area that is adjacent to the nose, causing the nasal sinus airways to narrow. This causes an increase in the velocity of flow through the upper anatomical airways and a decrease in the lateral pressure against the nasal mucosal walls. Additionally, the tubing may fold undesirably exacerbating the above problem.
  • a first exemplary embodiment of the present invention provides a nasal ventilation interface including a cannula connectable to a source of ventilation gas via at least two ventilation connectors including at least one reservoir flange in close proximity with at least one nasal insert.
  • the nasal ventilation interface further includes a seal portion positioned on a distal end of the at least one nasal insert and a central reservoir with at least one exhaust flange and an exhaust port positioned at a midpoint between the at least two ventilation connectors.
  • a nasal ventilation interface in a second exemplary embodiment, includes a cannula connectable to a source of ventilation gas via at least two ventilation connectors forming a first inflow portion.
  • a reservoir flange forms a second inflow portion with at least one nasal insert.
  • the nasal insert forms a bird inflow portion and a first outflow portion.
  • a seal portion with a substantially oval cross section is positioned on a distal end of the nasal insert.
  • a central reservoir forms a second outflow portion.
  • At least one exhaust flange forms a third outflow portion.
  • An exhaust port positioned at a midpoint between the at least two ventilation connectors forms a fourth outflow portion and a fifth outflow portion.
  • a third exemplary embodiment describes a ventilation interface system.
  • the system may include feed tubes, a y-connector and headgear engageable with a headgear flange on a cannula.
  • the ventilation connectors are connectable to a source of ventilation gas via the feed tubes and y-connector.
  • the at least two ventilation connectors form a first inflow portion.
  • a reservoir flange forms a second inflow portion.
  • At least one nasal insert and seal portion form a third inflow portion and a first outflow portion.
  • a central reservoir forms a second outflow portion.
  • At least one exhaust flange forms a third outflow portion.
  • An exhaust port positioned at a midpoint between the at least two ventilation connectors forms a fourth outflow portion and a fifth outflow portion.
  • FIG. 1 shows a left front elevation view of an exemplary embodiment of a ventilation interface.
  • FIG. 2 shows a front side view of an exemplary embodiment of a ventilation interface.
  • FIG. 3 shows a side view of an exemplary embodiment of a ventilation insert of FIG. 2 .
  • FIG. 4 shows a bottom view of an exemplary embodiment of the ventilation insert of FIG. 2 .
  • FIG. 5 shows a top view of the ventilation insert of FIG. 2 .
  • FIG. 6 shows a cross-sectional view taken from line I-I in FIG. 5 .
  • FIG. 7 shows an elevated front left view of a second exemplary embodiment of the nasal interface.
  • the source may apply a positive pressure through the cannula to the throat of the user, thereby permitting an adequate amount of oxygen or air to flow into the lungs.
  • a cannula 20 may include a pair of ventilation connectors 2 , at least one reservoir flange 4 , at least one nasal insert 6 , at least one seal portion 8 , a central reservoir 10 , an exhaust port 14 , and at least one connection portion 18 . These and other portions of the cannula 20 will now be further described.
  • Ventilation connectors 2 couple the cannula 20 to a ventilation source (not shown). Ventilation connectors 2 may be shaped and configured to connect to a wide variety of ventilation sources, such as a mechanical ventilator, pump, or tank. For example, ventilation connectors 2 may be configured to connect to a source of ventilation gas via one or more feed tubes and a y-connector (not shown). Other types of ventilation connectors may be used as part of the cannula 20 .
  • Nasal insert 6 provides a structure for extending the cannula 20 into a user's nares.
  • Nasal insert 6 may comprise at its distal end a seat portion 8 .
  • the seal portion 8 may have a substantially oval cross section in order to assist with fitting nasal insert 6 inside a user's nasal passages.
  • the seal portion 8 may also be configured to receive a skirt to prevent leakage.
  • Nasal insert 6 may also be coupled at its proximal end to the central reservoir 10 .
  • the seal portion 8 and/or at least one nasal insert 6 may be made of an elastic material.
  • the elastic material may be chosen such that its resiliency is sufficient to retain the cannula 20 in the nares of a user.
  • the seal portion 8 and/or the nasal insert 6 may expand in response to the positive pressure of the ventilation gas, thereby aiding in the retention of the cannula 8 within the nares.
  • the seal portion 8 may be retained entirely in the user's nares by friction between the seal portion 8 and the user's nares.
  • the nasal insert 6 and seal portion 8 may be made of less elastic material that deforms only slightly and instead the cannula 20 may be held in place by headgear (not shown) that is attached to the user.
  • Central reservoir 10 provides an additional volume of air or gas that, for example, allows for a decreased flow velocity through cannula 20 without a drop in pressure.
  • central reservoir 10 may be shaped in a variety of ways to optimize the airflow through the cannula 20 .
  • central reservoir 10 may be shaped to allow a laminar flow through the cannula 20 between the nasal insert 6 and the exhaust port 14 .
  • the central reservoir 10 may have a shape and volume that is sufficient to slow the velocity of air or gas without dropping its pressure. This feature may be considered useful in increasing the effectiveness of the cannula 20 for treating sleep apnea.
  • a ventilation interface system that uses the cannula 20 with the central reservoir 10 can provide the ventilation gas from the ventilation source to the nares at a lower velocity thereby decreasing a drop in pressure and with improved laminar flow because the central reservoir 10 can hold an increased volume of air or gas.
  • the resulting decrease in flow velocity decreases lateral pressure and in turn decreases the amount of moisture removed from the mucosal walls of a user, which increases the comfort of the user.
  • the ventilation interface system consistent with the principles of the present invention may provide better comfort and functionality and may be more economical to produce over the conventional systems.
  • an exhaust port 14 may be provided with central reservoir 10 .
  • the exhaust port 14 provides an outlet of air or gas from central reservoir 10 and assists with optimizing the airflow through the cannula 20 .
  • the exhaust port 14 may be positioned on the central reservoir 10 midway between the ventilation connectors 2 .
  • the cannula 20 may include a single exhaust port 14 with a substantially circular cross section.
  • the cannula 20 may include a single exhaust port 14 with a substantially oval cross section.
  • the substantially oval exhaust port 14 may be positioned, for example, on the central reservoir 10 midway between the ventilation connectors 2 .
  • the exhaust port 14 may be configured with a mechanism, such as a dial or valve, which increases or decreases the size of he internal diameter of the exhaust port 14 and varies the exhaust flow. This would enable various settings to be fitted to the various embodiments of the present invention.
  • a doctor could prescribe a particular aperture setting to accommodate a particular patient's needs, thereby reducing the tendency for incoming pressure to overpower the elasticity of the lungs and prevent exhalation
  • the mechanism may be helpful for CPAP users or other patients prescribed with excessive pressures ranging from 3 cmH 2 O to 25 cm H 2 O or higher.
  • the ranges may be from 5 cm-H 2 O to 20 cmH 2 O, 8 cmH 2 O to 15 cmH 2 O or 10 cmH 2 O to 12 cmH 2 O.
  • the mechanism may be integrated or removable from the cannula 20 and configured to facilitate flow of any type of gas that may be used in a dental office or hospital.
  • the cannula 20 may be fitted with a mechanism to allow for the administration of general anesthesia or other type of gas, such as a local anesthetic gas.
  • the cannula 20 may also include the connection portion 18 , which provides a coupling structure for nasal insert 6 .
  • connection portion 18 may be configured to allow for removable nasal inserts, such as nasal insert 6 .
  • Nasal insert 6 may, for example, be removable and replaceable for cleaning or may come in different sizes.
  • connection portion 18 may provide a structure for attaching other components to the cannula 20 , such as a flange, connector, or loop for a strap or headgear.
  • FIG. 2 a front side view is shown of an exemplary embodiment of the cannula 20 .
  • an exhaust flange 12 is now illustrated. As shown, the exhaust flange 12 extends from the central reservoir 10 and leads to the exhaust port 14 .
  • FIG. 2 also shows that the exhaust flange 12 and the exhaust port 14 may be positioned at a midpoint between the ventilation connectors 2 . Of course other positions for the exhaust flange 12 and the exhaust port 14 may be used.
  • the exhaust flange 12 and exhaust port 14 may be configured to smooth the transition of air releasing out of the central reservoir 10 .
  • the exhaust flange 12 may have a decreasing circumference as it extends to exhaust port 14 .
  • exhaust flange 12 may have lever 13 .
  • Lever 13 may be moved, for example rotated around exhaust flange 12 , in order to adjust the circumference of exhaust port 14 .
  • FIGS. 3, 4 , and 5 different views are shown of an exemplary embodiment of the cannula 20 .
  • FIG. 3 shows a side view of the cannula 20 and illustrates the general shapes of connectors 2 , reservoir flange 4 , the nasal insert 6 , and the seal portion 8 .
  • FIG. 4 shows a bottom view of the cannula 20 and illustrates the general shapes and locations of the connectors 2 , the central reservoir 10 , lever 13 , and the adjustable exhaust port 14 .
  • FIG. 5 shows a top view of the cannula 20 and illustrates the general shape and arrangement of the connectors 2 , nasal insert 6 , and the seal portion 8 .
  • FIG. 6 illustrates a cross-sectional view taken from line I-I in FIG. 5 and the general paths of flow through the cannula 20 .
  • a first inflow portion 24 may begin in the cannula 20 from a ventilation source (not shown).
  • the reservoir flange 4 forms a second inflow portion 26 which leads to nasal insert 6 .
  • Nasal insert 6 then forms a third inflow portion 28 , which eventually leads into the nasal passages of the user.
  • the nasal insert 6 forms a first outflow portion 30 .
  • the central reservoir 10 then forms a second outflow portion 32 .
  • the central reservoir 10 may be shaped and configured such that the velocity of outflow portion 32 may be reduced without substantially affecting the pressure of the inflow portions or outflow portions.
  • the exhaust flange 12 then forms a third outflow portion 34 .
  • the exhaust port 14 is configured and shaped to form a fourth outflow portion 36 and a fifth outflow portion 38 .
  • the fifth outflow portion 38 is then expelled out of exhaust port 14 .
  • the exhaust port 14 , the nasal insert 6 , and the central reservoir 10 may be configured to allow for improved laminar flow by flow portions 24 , 26 , 28 , 30 , 32 , and 34 .
  • the volume of the central reservoir 10 creates room for the gas and decreases the flow velocity of these flow portions and decreases the pressure drop. This decrease in flow velocity reduces any dryness and irritation that a user may otherwise have as a reset of higher flow velocities which increase the venturi effect along the nasal mucosa membrane.
  • the cannula 20 will increase the desired amount of pressure that prevents the apneas by increasing the number of air molecules.
  • the central reservoir 10 may allow for more laminar flow between the inflow portions 24 , 26 , and 28 and the outflow portions 30 , 32 , 34 , and 36 .
  • the central reservoir 10 further reduce the likelihood of any tornadic activity between the second inflow portion 26 and second 32 and third 34 outflow portions.
  • the exhaust flange 12 and the exhaust port 14 may be shaped and configured to optimize a venturi or similar effect between the third 36 and fourth outflow 38 portions.
  • the exhaust flange 12 at its top surface 40 may have a certain diameter that decreases as it extends to the exhaust port 14 . This narrowing of the exhaust flange 12 and exhaust port 14 may cause a venture effect as outflow portion 36 is expelled into outflow portion 38 .
  • the exhaust port 14 may also include a mechanism, such as an adjustable dial or valve, that adjusts the aperture of the exhaust port 14 .
  • FIG. 7 shows an elevated front left view of another exemplary embodiment of the cannula 20 .
  • the cannula 20 may also include at least one headgear flange 16 .
  • the cannula 20 may be held in place by headgear (not shown), which is attached to the U-shaped headgear connector 16 .
  • the headgear flange 16 may be attached to an exterior portion of the cannula 20 , such as at the connection portion 18 .
  • Headgear (not shown) may attach to the headgear flange 16 and/or connection portion 18 via velcro®, snap, button, latch, loop or any other conventional connecting means.

Abstract

A ventilation interface and system is described which can be adapted to be connected to a source of ventilation. The ventilation interface and system includes an exhaust port positioned at a midpoint between at least two ventilation connectors. The ventilation interface system may optionally include feed tubes, y-connector, tube holder, and headgear.

Description

    CROSS-REFERENCE TO RELATED APPLICATION
  • This application is a continuation of application Ser. No. 111008,669 which is a continuation in part of application Ser. No. 10/830,034 entitled “NASAL VENTILATION INTERFACE AND SYSTEM,” filed Apr. 23, 2004 and claims benefit under 35 U.S.C. 120. Additionally, this application claim the benefit to U.S. Provisional Patent Application No. 60/501,028, entitled “Ultimate Performance Cannula,” filed Sep. 9, 2003, and U.S. Provisional Patent Application No. 60/492,282, entitled “Variable Exhaust Ports,” filed Aug. 5, 2003, the disclosures of which are expressly incorporated by reference herein in their entirety.
  • BACKGROUND OF THE INVENTION
  • 1. Field of the Invention
  • Exemplary embodiments of the invention are directed to a nasal ventilation interface adaptable to be connected to a source of ventilation
  • 2. Discussion of Related Art
  • Obstructive sleep apnea syndrome (commonly referred to as obstructive sleep apnea, sleep apnea syndrome, and/or sleep apnea) is a medical condition which includes repeated, prolonged episodes of cessation of breathing during sleep. During a period of wakefulness, the muscles of the upper part of the throat passage of an individual keep the passage open, thereby permitting an adequate amount of oxygen to flow into the lungs. During sleep, the throat passage tends to narrow due to the relaxation of the muscles. In those individuals having a relatively normally sized throat passage, the narrowed throat passage remains open enough to continue to permit the adequate amount of oxygen to flow into the lungs. However, in those individuals having a relatively smaller sized throat passage, the narrowed throat passage prohibits the adequate amount of oxygen from flowing into the lungs. Additionally, a nasal obstruction, such as a relatively laze tongue, and/or certain shapes of the palate and/or the jaw of the individual further prohibit the adequate amount of oxygen from flowing into the lungs.
  • The individual having the above discussed conditions can stop breathing for one or more prolonged periods of time (e.g., 10 seconds or more). The prolonged periods of time during which breathing is stopped, or apneas, are generally followed by reflexive attempts to breathe. The reflexive attempts to breathe are generally accompanied by a change from a relatively deeper stage of sleep to a relatively lighter stage of sleep. As a result, the individual suffering from obstructive sleep apnea syndrome generally experiences fragmented sleep that is not restful. The fragmented sleep results in one or more of excessive and/or inappropriate daytime drowsiness, headache, weight gain or loss, limited attention span, memory loss, poor judgment, personality changes, lethargy, inability to maintain concentration, and/or depression.
  • Other medical conditions can also prevent individuals, including adults and infants, from receiving the adequate amount of oxygen into the lungs. For example, an infant who is born prematurely can have lungs that are not developed to an extent necessary to receive the adequate amount of oxygen. Further, prior to, during, and/or subsequent to certain medical procedures and/or medical treatments, an individual can be unable to receive the adequate amount of oxygen.
  • Under these circumstances, it is known to use a ventilation interface to apply a positive pressure to the throat of the individual, thereby permitting the adequate amount of oxygen to flow into the lungs. In the known ventilation interface, oxygen and/or room air containing oxygen is delivered through the mouth and/or nose of the individual. Known types of positive pressure applied by the known ventilation interface include continuous positive airway pressure (CPAP) in which a positive pressure is maintained in the throat passage throughout a respiratory cycle, bi-level positive airway pressure (BiPAP) in which a relatively high positive pressure is maintained during inspiration and a relatively low positive pressure is maintained during expiration, and intermittent mechanical positive pressure ventilation (IPPV) in which a positive pressure is applied when apnea is sensed (i.e., the positive airway pressure is applied intermittently or non-continuously).
  • One conventional ventilation interface for he application of such positive pressures includes a face mask that covers the nose and/or mouth, as well as a pair of nasal pillows that are inserted into corresponding nares of the naris.
  • In the conventional art, pressure must be applied between the required harness and the head of the individual to maintain the required seal. As a result, the harness is generally uncomfortable to wear, particularly when sleeping. The applied pressure often results in undesirable irritation and sores caused by movement of the mask and harness during periods of both wakefulness and sleep. Further, the required seal is generally difficult to maintain when the mask and harness is moved. The mask also generally applies an undesirable pressure to the sinus area that is adjacent to the nose, causing the nasal sinus airways to narrow. This causes an increase in the velocity of flow through the upper anatomical airways and a decrease in the lateral pressure against the nasal mucosal walls. Additionally, the tubing may fold undesirably exacerbating the above problem. The above-discussed combination of increased flow velocity and decreased pressure results in the removal of moisture from the mucosal walls during inspiration and may cause an undesirable drying and a burning sensation within the nares. As a result, the individual may remove the mask to alleviate these discomforts, consequently discontinuing the beneficial application of the positive pressure. Additionally the decreased pressure and increased air flow velocity deteriorate the laminar flow between the air input and output portions of the conventional mask.
  • For these reasons, it is desirable to provide an improved nasal ventilation interface that overcomes one or more of the above-discussed disadvantages.
  • SUMMARY OF THE EXEMPLARY EMBODIMENTS OF THE INVENTION
  • A first exemplary embodiment of the present invention provides a nasal ventilation interface including a cannula connectable to a source of ventilation gas via at least two ventilation connectors including at least one reservoir flange in close proximity with at least one nasal insert. The nasal ventilation interface further includes a seal portion positioned on a distal end of the at least one nasal insert and a central reservoir with at least one exhaust flange and an exhaust port positioned at a midpoint between the at least two ventilation connectors.
  • In a second exemplary embodiment, a nasal ventilation interface includes a cannula connectable to a source of ventilation gas via at least two ventilation connectors forming a first inflow portion. A reservoir flange forms a second inflow portion with at least one nasal insert. The nasal insert forms a bird inflow portion and a first outflow portion. A seal portion with a substantially oval cross section is positioned on a distal end of the nasal insert. A central reservoir forms a second outflow portion. At least one exhaust flange forms a third outflow portion. An exhaust port positioned at a midpoint between the at least two ventilation connectors forms a fourth outflow portion and a fifth outflow portion.
  • A third exemplary embodiment describes a ventilation interface system. The system may include feed tubes, a y-connector and headgear engageable with a headgear flange on a cannula. The ventilation connectors are connectable to a source of ventilation gas via the feed tubes and y-connector. The at least two ventilation connectors form a first inflow portion. A reservoir flange forms a second inflow portion. At least one nasal insert and seal portion form a third inflow portion and a first outflow portion. A central reservoir forms a second outflow portion. At least one exhaust flange forms a third outflow portion. An exhaust port positioned at a midpoint between the at least two ventilation connectors forms a fourth outflow portion and a fifth outflow portion.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • Reference will now be made to the exemplary embodiments of the invention, examples of which are illustrated in the accompanying drawings. Wherever possible, the same reference numbers will be used throughout the drawings to refer to the same or like parts
  • FIG. 1 shows a left front elevation view of an exemplary embodiment of a ventilation interface.
  • FIG. 2 shows a front side view of an exemplary embodiment of a ventilation interface.
  • FIG. 3 shows a side view of an exemplary embodiment of a ventilation insert of FIG. 2.
  • FIG. 4 shows a bottom view of an exemplary embodiment of the ventilation insert of FIG. 2.
  • FIG. 5 shows a top view of the ventilation insert of FIG. 2.
  • FIG. 6 shows a cross-sectional view taken from line I-I in FIG. 5.
  • FIG. 7 shows an elevated front left view of a second exemplary embodiment of the nasal interface.
  • Other embodiments of the invention will be apparent to those skilled in the art from consideration of the specification and practice of the invention disclosed herein. It is intended that the specification and examples be considered as exemplary only, with a true scope and spirit of the invention being indicated by the following claims.
  • DETAILED DESCRIPTION OF THE EXEMPLARY EMBODIMENTS
  • The present invention provides a nasal ventilation interface system that may include a cannula that is configured to be connected to a ventilation source. The cannula may connect to a source of ventilation gas, such as oxygen and/or air containing oxygen. For example, the cannula may include a distal end that connects to a feed tube. The feed tube may then lead to a branch of a y-connector. The y-connector may then have an exterior surface and an interior surface that define a wall portion therebetween, and each of the exterior and interior surfaces may have a substantially circular or oval cross section. The y-connector may then have another branch that is connected with the source of the ventilation gas, such as a mechanical ventilator or some other source of gas. The source may apply a positive pressure through the cannula to the throat of the user, thereby permitting an adequate amount of oxygen or air to flow into the lungs. Although the figures show certain exemplary embodiments of the nasal ventilation system, it is to be understood that the ventilation system can be of any type. One or more exemplary embodiments of the present invention will now be described with reference to the drawings, wherein like reference numbers throughout the several views identify like and/or similar elements.
  • For example, as shown in FIG. 1, a cannula 20 may include a pair of ventilation connectors 2, at least one reservoir flange 4, at least one nasal insert 6, at least one seal portion 8, a central reservoir 10, an exhaust port 14, and at least one connection portion 18. These and other portions of the cannula 20 will now be further described.
  • Ventilation connectors 2 couple the cannula 20 to a ventilation source (not shown). Ventilation connectors 2 may be shaped and configured to connect to a wide variety of ventilation sources, such as a mechanical ventilator, pump, or tank. For example, ventilation connectors 2 may be configured to connect to a source of ventilation gas via one or more feed tubes and a y-connector (not shown). Other types of ventilation connectors may be used as part of the cannula 20.
  • Reservoir flange 4 provides a reservoir for air to flow from the ventilation connector 2 to other parts of the cannula 20. For example, reservoir flange 4 may be coupled to the nasal insert 6, the central reservoir 10, and the exhaust flange 12.
  • Nasal insert 6 provides a structure for extending the cannula 20 into a user's nares. Nasal insert 6 may comprise at its distal end a seat portion 8. The seal portion 8 may have a substantially oval cross section in order to assist with fitting nasal insert 6 inside a user's nasal passages. The seal portion 8 may also be configured to receive a skirt to prevent leakage. Nasal insert 6 may also be coupled at its proximal end to the central reservoir 10.
  • The seal portion 8 and/or at least one nasal insert 6 may be made of an elastic material. The elastic material may be chosen such that its resiliency is sufficient to retain the cannula 20 in the nares of a user. Further, the seal portion 8 and/or the nasal insert 6 may expand in response to the positive pressure of the ventilation gas, thereby aiding in the retention of the cannula 8 within the nares. The seal portion 8 may be retained entirely in the user's nares by friction between the seal portion 8 and the user's nares. Alternatively, the nasal insert 6 and seal portion 8 may be made of less elastic material that deforms only slightly and instead the cannula 20 may be held in place by headgear (not shown) that is attached to the user.
  • Central reservoir 10 provides an additional volume of air or gas that, for example, allows for a decreased flow velocity through cannula 20 without a drop in pressure. In addition, central reservoir 10 may be shaped in a variety of ways to optimize the airflow through the cannula 20.
  • For example, central reservoir 10 may be shaped to allow a laminar flow through the cannula 20 between the nasal insert 6 and the exhaust port 14. In particular, the central reservoir 10 may have a shape and volume that is sufficient to slow the velocity of air or gas without dropping its pressure. This feature may be considered useful in increasing the effectiveness of the cannula 20 for treating sleep apnea.
  • During sleep, the exhalation of a person is driven by the elasticity of the lungs. For patients that use conventional sleep apnea devices, the contractioncontaction of the lungs during exhalation can become static during sleep, which interrupts the adequate exhalation and release of carbon dioxide. This happens frequently with some patients prescribed with conventional sleep apnea devices that use pressures of 3 cmH2O to 25 cm H2O or higher. These conventional devices sometimes have extreme variations in continuous positive airway pressures, greater than the elasticity of the lung.
  • In contrast, in accordance with some embodiments of the present invention, a ventilation interface system that uses the cannula 20 with the central reservoir 10 can provide the ventilation gas from the ventilation source to the nares at a lower velocity thereby decreasing a drop in pressure and with improved laminar flow because the central reservoir 10 can hold an increased volume of air or gas. The resulting decrease in flow velocity decreases lateral pressure and in turn decreases the amount of moisture removed from the mucosal walls of a user, which increases the comfort of the user. Accordingly, the ventilation interface system consistent with the principles of the present invention may provide better comfort and functionality and may be more economical to produce over the conventional systems.
  • Referring now back to FIG. 1, an exhaust port 14 may be provided with central reservoir 10. The exhaust port 14 provides an outlet of air or gas from central reservoir 10 and assists with optimizing the airflow through the cannula 20. For example, as shown in FIG. 1, the exhaust port 14 may be positioned on the central reservoir 10 midway between the ventilation connectors 2. The cannula 20 may include a single exhaust port 14 with a substantially circular cross section.
  • In another embodiment according to FIG. 1, the cannula 20 may include a single exhaust port 14 with a substantially oval cross section. Similarly to the above embodiment, the substantially oval exhaust port 14 may be positioned, for example, on the central reservoir 10 midway between the ventilation connectors 2.
  • Alternatively, the exhaust port 14 may be configured with a mechanism, such as a dial or valve, which increases or decreases the size of he internal diameter of the exhaust port 14 and varies the exhaust flow. This would enable various settings to be fitted to the various embodiments of the present invention.
  • As one non-limiting example, a doctor could prescribe a particular aperture setting to accommodate a particular patient's needs, thereby reducing the tendency for incoming pressure to overpower the elasticity of the lungs and prevent exhalation For example, the mechanism may be helpful for CPAP users or other patients prescribed with excessive pressures ranging from 3 cmH2O to 25 cm H2O or higher. For some patients, the ranges may be from 5 cm-H2O to 20 cmH2O, 8 cmH2O to 15 cmH2O or 10 cmH2O to 12 cmH2O.
  • In addition to treating sleep apnea, the mechanism may be integrated or removable from the cannula 20 and configured to facilitate flow of any type of gas that may be used in a dental office or hospital. For example, the cannula 20 may be fitted with a mechanism to allow for the administration of general anesthesia or other type of gas, such as a local anesthetic gas.
  • Referring again back to FIG. 1, the cannula 20 may also include the connection portion 18, which provides a coupling structure for nasal insert 6. For example, connection portion 18 may be configured to allow for removable nasal inserts, such as nasal insert 6. Nasal insert 6 may, for example, be removable and replaceable for cleaning or may come in different sizes.
  • In addition, connection portion 18 may provide a structure for attaching other components to the cannula 20, such as a flange, connector, or loop for a strap or headgear.
  • Referring now to FIG. 2, a front side view is shown of an exemplary embodiment of the cannula 20. In addition to the components previously described with reference to FIG. 1, an exhaust flange 12 is now illustrated. As shown, the exhaust flange 12 extends from the central reservoir 10 and leads to the exhaust port 14. FIG. 2 also shows that the exhaust flange 12 and the exhaust port 14 may be positioned at a midpoint between the ventilation connectors 2. Of course other positions for the exhaust flange 12 and the exhaust port 14 may be used.
  • The exhaust flange 12 and exhaust port 14 may be configured to smooth the transition of air releasing out of the central reservoir 10. For example, as shown in FIG. 2, the exhaust flange 12 may have a decreasing circumference as it extends to exhaust port 14. Additionally, exhaust flange 12 may have lever 13. Lever 13 may be moved, for example rotated around exhaust flange 12, in order to adjust the circumference of exhaust port 14.
  • Referring now to FIGS. 3, 4, and 5, different views are shown of an exemplary embodiment of the cannula 20. In particular, FIG. 3 shows a side view of the cannula 20 and illustrates the general shapes of connectors 2, reservoir flange 4, the nasal insert 6, and the seal portion 8. FIG. 4 shows a bottom view of the cannula 20 and illustrates the general shapes and locations of the connectors 2, the central reservoir 10, lever 13, and the adjustable exhaust port 14. FIG. 5 shows a top view of the cannula 20 and illustrates the general shape and arrangement of the connectors 2, nasal insert 6, and the seal portion 8.
  • FIG. 6 illustrates a cross-sectional view taken from line I-I in FIG. 5 and the general paths of flow through the cannula 20. For example, a first inflow portion 24 may begin in the cannula 20 from a ventilation source (not shown). The reservoir flange 4 forms a second inflow portion 26 which leads to nasal insert 6. Nasal insert 6 then forms a third inflow portion 28, which eventually leads into the nasal passages of the user.
  • During exhalation by the user, the nasal insert 6 forms a first outflow portion 30. The central reservoir 10 then forms a second outflow portion 32. As noted above, the central reservoir 10 may be shaped and configured such that the velocity of outflow portion 32 may be reduced without substantially affecting the pressure of the inflow portions or outflow portions. The exhaust flange 12 then forms a third outflow portion 34. The exhaust port 14 is configured and shaped to form a fourth outflow portion 36 and a fifth outflow portion 38. The fifth outflow portion 38 is then expelled out of exhaust port 14.
  • The exhaust port 14, the nasal insert 6, and the central reservoir 10 may be configured to allow for improved laminar flow by flow portions 24, 26, 28, 30, 32, and 34. In particular, the volume of the central reservoir 10 creates room for the gas and decreases the flow velocity of these flow portions and decreases the pressure drop. This decrease in flow velocity reduces any dryness and irritation that a user may otherwise have as a reset of higher flow velocities which increase the venturi effect along the nasal mucosa membrane. The cannula 20 will increase the desired amount of pressure that prevents the apneas by increasing the number of air molecules. Additionally, the central reservoir 10 may allow for more laminar flow between the inflow portions 24, 26, and 28 and the outflow portions 30, 32, 34, and 36. The central reservoir 10 further reduce the likelihood of any tornadic activity between the second inflow portion 26 and second 32 and third 34 outflow portions.
  • Furthermore, the exhaust flange 12 and the exhaust port 14 may be shaped and configured to optimize a venturi or similar effect between the third 36 and fourth outflow 38 portions. In particular, the exhaust flange 12 at its top surface 40 may have a certain diameter that decreases as it extends to the exhaust port 14. This narrowing of the exhaust flange 12 and exhaust port 14 may cause a venture effect as outflow portion 36 is expelled into outflow portion 38. As described above, the exhaust port 14 may also include a mechanism, such as an adjustable dial or valve, that adjusts the aperture of the exhaust port 14.
  • FIG. 7 shows an elevated front left view of another exemplary embodiment of the cannula 20. In particular, in addition to the components shown in FIGS. 1-5, the cannula 20 may also include at least one headgear flange 16. As previously described, the cannula 20 may be held in place by headgear (not shown), which is attached to the U-shaped headgear connector 16. The headgear flange 16 may be attached to an exterior portion of the cannula 20, such as at the connection portion 18. Headgear (not shown) may attach to the headgear flange 16 and/or connection portion 18 via velcro®, snap, button, latch, loop or any other conventional connecting means.
  • Numerous additional modifications and variations of the exemplary embodiment of the present invention are possible in light of the above teachings. It is therefore to be understood that within the scope of the appended claims, exemplary embodiments of the present invention may be practiced otherwise than as specifically described herein.

Claims (7)

1-20. (canceled)
21. An adjustable slide interface comprising:
an adjustable slide attachable to a ventilation interface with at least one flow velocity opening;
wherein moving the adjustable slide adjusts the size of the at least one flow velocity opening.
22. The adjustable slide interface of claim 21 wherein the at least one flow velocity opening is at least one exhaust opening.
23. The adjustable slide interface of claim 21 wherein the at least one flow velocity opening is two or more apertures.
24. The adjustable slide interface of claim 21 wherein the adjustable slide is a dial mechanism.
25. The adjustable slide interface of claim 21 wherein the adjustable slide is a valve mechanism.
26. The adjustable slide interface of claim 21 wherein the adjustable slide is laterally movable across the at least one flow velocity opening.
US11/806,773 2003-08-05 2007-06-04 Nasal ventilation interface and system Abandoned US20070251529A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/806,773 US20070251529A1 (en) 2003-08-05 2007-06-04 Nasal ventilation interface and system

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US49228203P 2003-08-05 2003-08-05
US50102803P 2003-09-09 2003-09-09
US10/830,034 US20060150982A1 (en) 2003-08-05 2004-04-23 Nasal ventilation interface and system
US11/008,669 US7234465B2 (en) 2003-08-05 2004-12-10 Nasal ventilation interface and system
US11/806,773 US20070251529A1 (en) 2003-08-05 2007-06-04 Nasal ventilation interface and system

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US11/008,669 Continuation US7234465B2 (en) 2003-08-05 2004-12-10 Nasal ventilation interface and system

Publications (1)

Publication Number Publication Date
US20070251529A1 true US20070251529A1 (en) 2007-11-01

Family

ID=34198943

Family Applications (3)

Application Number Title Priority Date Filing Date
US10/830,034 Abandoned US20060150982A1 (en) 2000-03-13 2004-04-23 Nasal ventilation interface and system
US11/008,669 Active 2024-07-14 US7234465B2 (en) 2003-08-05 2004-12-10 Nasal ventilation interface and system
US11/806,773 Abandoned US20070251529A1 (en) 2003-08-05 2007-06-04 Nasal ventilation interface and system

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US10/830,034 Abandoned US20060150982A1 (en) 2000-03-13 2004-04-23 Nasal ventilation interface and system
US11/008,669 Active 2024-07-14 US7234465B2 (en) 2003-08-05 2004-12-10 Nasal ventilation interface and system

Country Status (2)

Country Link
US (3) US20060150982A1 (en)
WO (2) WO2005016402A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9265458B2 (en) 2012-12-04 2016-02-23 Sync-Think, Inc. Application of smooth pursuit cognitive testing paradigms to clinical drug development
US9380976B2 (en) 2013-03-11 2016-07-05 Sync-Think, Inc. Optical neuroinformatics

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6024089A (en) 1997-03-14 2000-02-15 Nelcor Puritan Bennett Incorporated System and method for setting and displaying ventilator alarms
US20070137653A1 (en) 2000-03-13 2007-06-21 Wood Thomas J Ventilation interface for sleep apnea therapy
DE10035946C2 (en) * 2000-07-21 2002-06-27 Map Gmbh Bracket for a breathing mask
US6679265B2 (en) 2001-10-25 2004-01-20 Worldwide Medical Technologies Nasal cannula
AUPS192602A0 (en) * 2002-04-23 2002-05-30 Resmed Limited Nasal mask
US7743767B2 (en) 2002-04-23 2010-06-29 Resmed Limited Ergonomic and adjustable respiratory mask assembly with frame
US8997742B2 (en) 2002-04-23 2015-04-07 Resmed Limited Ergonomic and adjustable respiratory mask assembly with cushion
NZ562412A (en) 2003-02-21 2009-02-28 Resmed Ltd Nasal assembly for pillow mask
US7588033B2 (en) 2003-06-18 2009-09-15 Breathe Technologies, Inc. Methods, systems and devices for improving ventilation in a lung area
US8381729B2 (en) 2003-06-18 2013-02-26 Breathe Technologies, Inc. Methods and devices for minimally invasive respiratory support
JP2007506480A (en) 2003-08-18 2007-03-22 ワンドカ,アンソニー・ディ Methods and apparatus for non-invasive ventilation with a nasal interface
JP2006198093A (en) * 2005-01-19 2006-08-03 Izumi Products Co Rotary electric shaver
EP1926517A2 (en) 2005-09-20 2008-06-04 Lutz Freitag Systems, methods and apparatus for respiratory support of a patient
US8100125B2 (en) 2005-09-30 2012-01-24 Carefusion 207, Inc. Venturi geometry design for flow-generator patient circuit
WO2007041786A1 (en) * 2005-10-14 2007-04-19 Resmed Ltd Nasal assembly
US8021310B2 (en) 2006-04-21 2011-09-20 Nellcor Puritan Bennett Llc Work of breathing display for a ventilation system
CN101541365A (en) 2006-05-18 2009-09-23 呼吸科技公司 Tracheostoma tracheotomy method and device
US9943660B2 (en) 2006-08-04 2018-04-17 Resmed Limited Nasal prongs for mask system
US7784461B2 (en) 2006-09-26 2010-08-31 Nellcor Puritan Bennett Llc Three-dimensional waveform display for a breathing assistance system
CN103418070B (en) 2006-12-15 2017-03-01 瑞思迈有限公司 Delivery of respiratory therapy
WO2008144589A1 (en) 2007-05-18 2008-11-27 Breathe Technologies, Inc. Methods and devices for sensing respiration and providing ventilation therapy
JP5513392B2 (en) 2007-09-26 2014-06-04 ブリーズ・テクノロジーズ・インコーポレーテッド Method and apparatus for treating sleep apnea
US8567399B2 (en) 2007-09-26 2013-10-29 Breathe Technologies, Inc. Methods and devices for providing inspiratory and expiratory flow relief during ventilation therapy
US8770193B2 (en) 2008-04-18 2014-07-08 Breathe Technologies, Inc. Methods and devices for sensing respiration and controlling ventilator functions
WO2009151791A2 (en) 2008-04-18 2009-12-17 Breathe Technologies, Inc. Methods and devices for sensing respiration and controlling ventilator functions
JP5715950B2 (en) 2008-08-22 2015-05-13 ブリーズ・テクノロジーズ・インコーポレーテッド Method and apparatus for providing mechanical ventilation with an open airway interface
EP2344791B1 (en) 2008-10-01 2016-05-18 Breathe Technologies, Inc. Ventilator with biofeedback monitoring and control for improving patient activity and health
AU2015203493B2 (en) * 2008-12-01 2017-08-17 Fisher & Paykel Healthcare Limited Nasal cannula
US8430098B1 (en) 2008-12-17 2013-04-30 Venkata Buddharaju Strapless nasal interface device
US20180064900A1 (en) 2008-12-17 2018-03-08 Venkata Buddharaju Strapless nasal interface device
US9132250B2 (en) 2009-09-03 2015-09-15 Breathe Technologies, Inc. Methods, systems and devices for non-invasive ventilation including a non-sealing ventilation interface with an entrainment port and/or pressure feature
EP4218876A1 (en) 2009-04-02 2023-08-02 Breathe Technologies, Inc. Systems for non-invasive open ventilation with gas delivery nozzles within an outer tube
US9962512B2 (en) 2009-04-02 2018-05-08 Breathe Technologies, Inc. Methods, systems and devices for non-invasive ventilation including a non-sealing ventilation interface with a free space nozzle feature
CN102762250B (en) 2009-09-03 2017-09-26 呼吸科技公司 Mthods, systems and devices for including the invasive ventilation with entrainment port and/or the non-tight vented interface of pressure characteristic
US8335992B2 (en) 2009-12-04 2012-12-18 Nellcor Puritan Bennett Llc Visual indication of settings changes on a ventilator graphical user interface
US9119925B2 (en) 2009-12-04 2015-09-01 Covidien Lp Quick initiation of respiratory support via a ventilator user interface
US8924878B2 (en) 2009-12-04 2014-12-30 Covidien Lp Display and access to settings on a ventilator graphical user interface
US9262588B2 (en) 2009-12-18 2016-02-16 Covidien Lp Display of respiratory data graphs on a ventilator graphical user interface
US8499252B2 (en) 2009-12-18 2013-07-30 Covidien Lp Display of respiratory data graphs on a ventilator graphical user interface
EP2605836A4 (en) 2010-08-16 2016-06-01 Breathe Technologies Inc Methods, systems and devices using lox to provide ventilatory support
CN103124575B (en) 2010-09-30 2015-12-16 呼吸科技公司 For the mthods, systems and devices of moistening respiratory tract
US10362967B2 (en) 2012-07-09 2019-07-30 Covidien Lp Systems and methods for missed breath detection and indication
US20150231443A1 (en) * 2012-08-13 2015-08-20 Christopher I. Halliday Pulmonary system resistance training apparatus and methods
KR102223425B1 (en) 2012-12-04 2021-03-08 말린크로트 하스피탈 프로덕츠 아이피 리미티드 Cannula for minimizing dilution of dosing during nitric oxide delivery
US9795756B2 (en) 2012-12-04 2017-10-24 Mallinckrodt Hospital Products IP Limited Cannula for minimizing dilution of dosing during nitric oxide delivery
CN104853794B (en) * 2012-12-11 2017-11-07 皇家飞利浦有限公司 nasal cannula system and method
US10716908B2 (en) * 2013-08-06 2020-07-21 Fisher & Paykel Healthcare Limited Infant CPAP device, interface and system
US9950129B2 (en) 2014-10-27 2018-04-24 Covidien Lp Ventilation triggering using change-point detection
US10792449B2 (en) 2017-10-03 2020-10-06 Breathe Technologies, Inc. Patient interface with integrated jet pump
US11672934B2 (en) 2020-05-12 2023-06-13 Covidien Lp Remote ventilator adjustment

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3097642A (en) * 1956-08-21 1963-07-16 Allan M Russell Face mask
US4549543A (en) * 1982-12-01 1985-10-29 Moon William F Air filtering face mask
US5425358A (en) * 1992-08-03 1995-06-20 Vital Signs, Inc. Pressure limiting valve for ventilation gas apparatus
US20020092527A1 (en) * 2000-03-13 2002-07-18 Wood Thomas J. Ventilation interface for sleep apnea therapy
US6478026B1 (en) * 1999-03-13 2002-11-12 Thomas J. Wood Nasal ventilation interface
US20050235999A1 (en) * 2004-04-23 2005-10-27 Wood Thomas J Nasal ventilation interface and system
US7191781B2 (en) * 2003-08-05 2007-03-20 Innomed Technologies, Inc. Nasal ventilation interface and system

Family Cites Families (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE146688C (en)
US1125542A (en) * 1914-03-11 1915-01-19 Aubrey Humphries Apparatus for use in administering anesthetics.
GB532214A (en) 1939-08-22 1941-01-20 Hayden Thomas Cattanach Improvements in and relating to nasal douches
US3670726A (en) * 1969-09-23 1972-06-20 Becton Dickinson Co Breathing circuit
US3739774A (en) * 1970-05-21 1973-06-19 Ml Aviation Co Ltd Respirators
GB1432767A (en) * 1972-08-25 1976-04-22 Carden Anaesthetists ventilator
DE2342521A1 (en) * 1972-08-29 1974-04-25 Paul Guichard PORTABLE NASAL DIFFUSER DEVICE FOR PURIFYING AND MODIFYING BREATHING AIR
US3905361A (en) * 1974-04-24 1975-09-16 Brunswick Mfg Co Inc Apparatus for sealing the esophagus and providing artificial respiration and evacuating the stomach
US4156426A (en) * 1977-08-11 1979-05-29 Gold Lawrence W Head-mounted oxygen-administration device
US4267845A (en) * 1978-10-05 1981-05-19 Robertson Jr Charles H Method and apparatus for measuring pulmonary ventilation
US4273124A (en) * 1979-06-01 1981-06-16 Zimmerman J Earl Nasal cannula
US4367735A (en) * 1979-12-31 1983-01-11 Novametrix Medical Systems, Inc. Nasal cannula
US4312359A (en) * 1980-02-19 1982-01-26 Life Care Systems, Inc. Noninvasive blood pressure measuring system
US4367816A (en) * 1981-06-10 1983-01-11 Wilkes Kenneth R Tear strip for gas sterilizable package and package
US4422456A (en) * 1981-09-08 1983-12-27 City Of Hope National Medical Center Nasal cannula structure
US4406283A (en) * 1982-02-04 1983-09-27 Phillip Bir Oxygen cannulae for continuous administration of oxygen, and its associated mounting structure and method for mounting same onto the head of a patient
US4493614A (en) * 1982-10-08 1985-01-15 Lifecare Services, Inc. Pump for a portable ventilator
US4549542A (en) * 1983-07-25 1985-10-29 Chien Chao Huei Multiple-effect respirator
US4774946A (en) * 1983-11-28 1988-10-04 Ackrad Laboratories, Inc. Nasal and endotracheal tube apparatus
US4601465A (en) * 1984-03-22 1986-07-22 Roy Jean Yves Device for stimulating the human respiratory system
US4660555A (en) * 1984-09-21 1987-04-28 Payton Hugh W Oxygen delivery and administration system
US4617637A (en) * 1985-07-09 1986-10-14 Lifecare Services, Inc. Servo control system for a reciprocating piston respirator
US4587967A (en) * 1985-07-09 1986-05-13 Lifecare Services, Inc. Oxygen enriched reciprocating piston respirator
US4699139A (en) * 1985-09-30 1987-10-13 Marshall Marie F Nasal cannula assembly with patient comfort pad
US4706664A (en) * 1986-04-11 1987-11-17 Puritan-Bennett Corporation Inspiration oxygen saver
US4753233A (en) * 1987-02-10 1988-06-28 Advantage Medical Nasal cannula
FR2623404A1 (en) * 1987-11-19 1989-05-26 Air Liquide RESPIRATORY ASSISTANCE DEVICE
US5335656A (en) * 1988-04-15 1994-08-09 Salter Laboratories Method and apparatus for inhalation of treating gas and sampling of exhaled gas for quantitative analysis
DE3823382C1 (en) * 1988-07-09 1990-01-11 Draegerwerk Ag, 2400 Luebeck, De
IL87156A (en) * 1988-07-20 1993-05-13 Eagle Forced-ventilation filtration unit particularly for respiration device
US4915105A (en) * 1988-10-28 1990-04-10 Lee Tien Chu Miniature respiratory apparatus
US4899740A (en) * 1989-01-17 1990-02-13 E. D. Bullard Company Respirator system for use with a hood or face mask
US4996983A (en) * 1989-01-31 1991-03-05 Amrhein Floyd E Inhaler filtration device with housing supportable by spectacle temple
AU5524490A (en) * 1989-04-13 1990-11-05 Salter Laboratories Demand oxygen system
US5265595A (en) * 1989-06-19 1993-11-30 Hans Rudolph, Inc. Mask for breath analysis
DK162426C (en) * 1989-09-04 1992-03-23 Ambu Int As PROTECTION AGENT FOR USE BY LUNGE VENTILATION BY ORAL ORAL OR Mouth-to-nose method
US5074297A (en) * 1989-12-19 1991-12-24 The General Hospital Corporation Self-sealing mask for delivering intermittent positive pressure ventilation
US5046491A (en) * 1990-03-27 1991-09-10 Derrick Steven J Apparatus and method for respired gas collection and analysis
US5025805A (en) * 1990-07-11 1991-06-25 Betty Nutter Nasal cannula assembly
US5121745A (en) * 1990-07-23 1992-06-16 Israel Michael B Self-inflatable rescue mask
US5113857A (en) * 1990-08-27 1992-05-19 Stair Dickerman Breathing gas delivery system and holding clip member therefor
FR2673380B1 (en) * 1991-02-28 1993-06-18 Intertechnique Sa PERSONAL RESPIRATORY PROTECTION EQUIPMENT.
US5954049A (en) * 1991-10-15 1999-09-21 Trudell Medical Limited Equine mask with MDI adapter
US5269296A (en) * 1991-10-29 1993-12-14 Landis Robert M Nasal continuous positive airway pressure apparatus and method
US5477852A (en) 1991-10-29 1995-12-26 Airways Ltd., Inc. Nasal positive airway pressure apparatus and method
US5687715A (en) * 1991-10-29 1997-11-18 Airways Ltd Inc Nasal positive airway pressure apparatus and method
US5188101A (en) * 1991-11-15 1993-02-23 Tumolo Jean S Premature baby headband for supporting nasal cannulas and oxygen feed tubes
USD333015S (en) * 1991-12-02 1993-02-02 Lifecare International, Inc. Nasal mask
US5271391A (en) * 1991-12-20 1993-12-21 Linda Graves Apparatus for delivering a continuous positive airway pressure to an infant
US5372130A (en) * 1992-02-26 1994-12-13 Djs&T Limited Partnership Face mask assembly and method having a fan and replaceable filter
US5355893A (en) * 1992-04-06 1994-10-18 Mick Peter R Vital signs monitor
US5385141A (en) * 1992-04-16 1995-01-31 Siebe North, Inc. Speech diaphragm and exhalation valve
US5396885A (en) * 1992-07-31 1995-03-14 Nelson; Joseph M. Mobile air supply cart having dual tanks and connections allowing simultaneous filling of tank and delivery of air to a user
US5299599A (en) * 1992-09-17 1994-04-05 Lifecare International, Inc. Valving arrangement for a negative pressure ventilator
US5394568A (en) * 1993-01-28 1995-03-07 Minnesota Mining And Manufacturing Company Molded head harness
US5400776A (en) * 1993-07-09 1995-03-28 Proprietary Technology, Inc. Apparatus for maintaining a bend in a medical insufflation tube
US5437267A (en) * 1993-08-03 1995-08-01 Weinstein; Allan Device for delivering aerosol to the nasal membranes and method of use
US5398676A (en) * 1993-09-30 1995-03-21 Press; Roman J. Portable emergency respirator
DK171592B1 (en) * 1993-12-21 1997-02-17 Maersk Medical As Device for supplying oxygen and / or other gases to a patient
US5375593A (en) * 1994-02-10 1994-12-27 Press; John R. Oxygenating pacifier
US5906203A (en) * 1994-08-01 1999-05-25 Safety Equipment Sweden Ab Breathing apparatus
US5425359A (en) * 1994-08-29 1995-06-20 Liou; Nan-Tien Nose plug structure with filter
US5509409A (en) * 1994-09-12 1996-04-23 The Living Trust Of Marjorie F. Weatherholt Nasal cannula assembly
US5533506A (en) * 1995-01-13 1996-07-09 Medlife, Inc. Nasal tube assembly
US5526806A (en) * 1995-04-04 1996-06-18 Sansoni; Jean Non-invasive nasal cannula
US5682881A (en) * 1996-10-21 1997-11-04 Winthrop; Neil Nasal CPAP/Cannula and securement apparatus
US5794619A (en) * 1997-02-18 1998-08-18 Edelman; Robert Nasal cannula mounted solely by frictional engagement with the columella
US6439234B1 (en) * 1998-04-03 2002-08-27 Salter Labs Nasal cannula
US6637434B2 (en) * 1998-10-30 2003-10-28 Linda J. Noble Nasal gas delivery system and method for use thereof
US6561193B1 (en) * 1998-10-30 2003-05-13 Linda J. Noble Nasal gas delivery apparatus and a nasal vestibular airway
US6595215B2 (en) * 2000-03-13 2003-07-22 Innomed Technologies, Inc. Ventilation interface for sleep apnea therapy
AU4910900A (en) * 1999-05-28 2000-12-18 Euromedico Ltd. Gas-supplying device
US6571798B1 (en) * 2000-04-05 2003-06-03 W. Keith Thornton Device for improving breathing and method of constructing same
FR2809317B1 (en) * 2000-05-26 2002-08-16 Taema NASAL RESPIRATORY MASK WITH ADJUSTABLE THERMISTANCE INTENDED FOR THE TREATMENT OF RESPIRATORY SLEEP DISORDERS
AUPQ821500A0 (en) 2000-06-19 2000-07-13 Australian Centre For Advanced Medical Technology Ltd Mask
US6561188B1 (en) * 2000-08-21 2003-05-13 Ellis Alan D Nasal breathing apparatus and methods
CA2447705A1 (en) * 2001-06-18 2002-12-27 Michael A. Riggins A nasal cannula apnea detection device
US6679265B2 (en) * 2001-10-25 2004-01-20 Worldwide Medical Technologies Nasal cannula
US20050061326A1 (en) * 2002-08-09 2005-03-24 Payne Charles E. Headwear for use by a sleep apnea patient
US6766800B2 (en) * 2002-08-30 2004-07-27 Sensormedics Corporation Pressure regulating valve for use in continuous positive airway pressure devices
NZ562412A (en) * 2003-02-21 2009-02-28 Resmed Ltd Nasal assembly for pillow mask
US7614401B2 (en) * 2003-08-06 2009-11-10 Paul S. Thompson Nasal cannula assembly
US7353826B2 (en) * 2003-08-08 2008-04-08 Cardinal Health 205, Inc. Sealing nasal cannula
WO2005079726A1 (en) 2004-02-23 2005-09-01 Fisher & Paykel Healthcare Limited Breathing assistance apparatus

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3097642A (en) * 1956-08-21 1963-07-16 Allan M Russell Face mask
US4549543A (en) * 1982-12-01 1985-10-29 Moon William F Air filtering face mask
US5425358A (en) * 1992-08-03 1995-06-20 Vital Signs, Inc. Pressure limiting valve for ventilation gas apparatus
US6478026B1 (en) * 1999-03-13 2002-11-12 Thomas J. Wood Nasal ventilation interface
US20020092527A1 (en) * 2000-03-13 2002-07-18 Wood Thomas J. Ventilation interface for sleep apnea therapy
US7191781B2 (en) * 2003-08-05 2007-03-20 Innomed Technologies, Inc. Nasal ventilation interface and system
US20050235999A1 (en) * 2004-04-23 2005-10-27 Wood Thomas J Nasal ventilation interface and system

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9265458B2 (en) 2012-12-04 2016-02-23 Sync-Think, Inc. Application of smooth pursuit cognitive testing paradigms to clinical drug development
US9380976B2 (en) 2013-03-11 2016-07-05 Sync-Think, Inc. Optical neuroinformatics

Also Published As

Publication number Publication date
US20050236000A1 (en) 2005-10-27
WO2005016407A3 (en) 2005-12-22
WO2005016402A3 (en) 2005-05-26
US7234465B2 (en) 2007-06-26
WO2005016402A2 (en) 2005-02-24
WO2005016407A2 (en) 2005-02-24
US20060150982A1 (en) 2006-07-13

Similar Documents

Publication Publication Date Title
US7234465B2 (en) Nasal ventilation interface and system
US7191781B2 (en) Nasal ventilation interface and system
US20050235999A1 (en) Nasal ventilation interface and system
US20050121037A1 (en) Nasal ventilation interface
US6997187B2 (en) Nasal interface and system including ventilation insert
US9919121B2 (en) Ventilation interface for sleep apnea therapy
US7000613B2 (en) Nasal interface and system including ventilation insert
US6997177B2 (en) Ventilation interface for sleep apnea therapy
US8881728B2 (en) System, method and ventilation interface for providing pressurized breathable gas to the mouth and nose separately
US6595215B2 (en) Ventilation interface for sleep apnea therapy
US7059328B2 (en) Ventilation interface for sleep apnea therapy
US7472707B2 (en) Nasal interface and system including ventilation insert
EP1317941B1 (en) Nasal ventilation cannula
CA2368825C (en) Ventilation interface for sleep apnea therapy
JP2024515882A (en) Patient Interface
WO2005016425A1 (en) Nasal interface and system including ventilation insert
CA2416410C (en) Ventilation interface for sleep apnea therapy

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION